Duke Health
Raleigh, North Carolina, United States, North America
Overview
Duke Health is a healthcare practice. They provide treatments for adults and children that include bariatric surgery, cancer care, cardiology, gastroenterology, ob-gyn, ophthalmology, orthopedic care, primary care, spine and back care, transplant, cancer care, cardiology, gastroenterology, general pediatrics, and more. Duke Health transforms medicine and health through innovative scientific research, the rapid translation of breakthrough discoveries, the education of future clinical and scientific leaders, the advocacy and practice of evidence-based medicine to improve community health, and the leadership of efforts to eliminate health inequalities.
- Total investments
- 1
- Lead investments
- 0
- Investments · 12mo
- 1
- Active investors
- 3
Sector focus
- Health Care
- Home Health Care
- Hospital
- Medical
- Oncology
- Primary and Urgent Care
Investment portfolio
- Cadence Solutions
Participated · Series C · Jun 2026
Cadence Solutions builds Clinical Intelligence that monitors patients with chronic disease, surfaces risks, and coordinates actions through supervised AI agents integrated into health systems' EMRs and workflows. The company works alongside more than 20 leading health systems and currently treats over 100,000 active patients. Peer-reviewed studies and real-world deployments cited in the company's materials show validated outcomes, including a 230% increase in heart-failure patients on guideline-directed medical therapy, a 70% relative increase in blood-pressure control for hypertension patients, a 27% reduction in hospital admissions, and a $1,302 per-patient annual reduction in total cost of care. Cadence reported it saves Medicare roughly $2.7 million every week and that its model returns more than $3 to Medicare for every dollar spent. Commercial traction includes tripling annual recurring revenue in 2025 and new affiliations with Duke Health and Texas Health Resources. With the Series C capital, Cadence plans to accelerate expansion into additional health systems, further develop its AI agents, and scale value-based care deployments.